Cultured AFB Antitubercular DST Rifampicin Test
Comprehensive Tuberculosis Drug Resistance Testing
The Cultured AFB Antitubercular DST Rifampicin Test represents a critical advancement in tuberculosis management, providing healthcare providers with essential information about drug susceptibility patterns. This specialized diagnostic test evaluates the effectiveness of rifampicin against Mycobacterium tuberculosis complex, helping to identify resistant strains that require alternative treatment approaches.
What This Test Measures and Detects
This sophisticated laboratory analysis specifically measures the susceptibility of Mycobacterium tuberculosis complex to rifampicin, one of the most important first-line anti-tuberculosis medications. The test detects:
- Rifampicin-sensitive tuberculosis strains
- Rifampicin-resistant tuberculosis strains
- Minimum inhibitory concentrations (MIC) for rifampicin
- Patterns of drug resistance that may indicate multidrug-resistant TB (MDR-TB)
Who Should Consider This Test
This test is recommended for individuals experiencing:
- Persistent cough lasting more than three weeks
- Unexplained weight loss and fatigue
- Night sweats and fever
- Chest pain and breathing difficulties
- Known exposure to tuberculosis patients
- Previous TB treatment failure
- Immunocompromised conditions increasing TB risk
- Healthcare workers with potential TB exposure
Key Benefits of Taking the Test
- Early Detection of Drug Resistance: Identify rifampicin-resistant strains before treatment initiation
- Personalized Treatment Planning: Guide physicians in selecting appropriate anti-TB medications
- Prevention of Treatment Failure: Avoid ineffective therapy that could lead to disease progression
- Reduced Transmission Risk: Proper management decreases community spread of drug-resistant TB
- Cost-Effective Healthcare: Prevent unnecessary medication expenses and hospitalizations
Understanding Your Test Results
Your test results will provide clear guidance on rifampicin susceptibility:
- Susceptible: The tuberculosis strain responds effectively to rifampicin treatment
- Resistant: The strain shows resistance to rifampicin, requiring alternative treatment strategies
- Intermediate: The strain shows reduced susceptibility, potentially needing higher doses or combination therapy
Your physician will interpret these results in the context of your clinical presentation and develop a comprehensive treatment plan tailored to your specific needs.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $100 |
| Regular Price | $126 |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing results nationwide.
Book Your Test Today
Take control of your respiratory health with our comprehensive tuberculosis drug resistance testing. Early detection of rifampicin resistance can significantly improve treatment outcomes and prevent complications. Contact us today to schedule your test and receive expert guidance from our infectious disease specialists.
Call or WhatsApp: +1(267) 388-9828
Our dedicated healthcare team is available to answer your questions, provide detailed test information, and help you schedule an appointment at your convenience. Don’t wait – proactive testing is your first step toward effective tuberculosis management and improved health outcomes.
